These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 9748559

  • 1. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
    Arias HR.
    Biochim Biophys Acta; 1998 Aug 21; 1376(2):173-220. PubMed ID: 9748559
    [Abstract] [Full Text] [Related]

  • 2. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
    Arias HR.
    Brain Res Brain Res Rev; 1997 Oct 21; 25(2):133-91. PubMed ID: 9403137
    [Abstract] [Full Text] [Related]

  • 3. Noncompetitive inhibition of nicotinic acetylcholine receptors by endogenous molecules.
    Arias HR.
    J Neurosci Res; 1998 May 15; 52(4):369-79. PubMed ID: 9589382
    [Abstract] [Full Text] [Related]

  • 4. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor.
    Arias HR.
    Mol Membr Biol; 1996 May 15; 13(1):1-17. PubMed ID: 9147657
    [Abstract] [Full Text] [Related]

  • 5. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
    Arias HR.
    Arch Biochem Biophys; 1999 Nov 01; 371(1):89-97. PubMed ID: 10525293
    [Abstract] [Full Text] [Related]

  • 6. Agonist self-inhibitory binding site of the nicotinic acetylcholine receptor.
    Arias HR.
    J Neurosci Res; 1996 Apr 15; 44(2):97-105. PubMed ID: 8723217
    [Abstract] [Full Text] [Related]

  • 7. The high-affinity quinacrine binding site is located at a non-annular lipid domain of the nicotinic acetylcholine receptor.
    Arias HR.
    Biochim Biophys Acta; 1997 Jul 12; 1347(1):9-22. PubMed ID: 9233683
    [Abstract] [Full Text] [Related]

  • 8. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
    Arias HR.
    Neurochem Int; 2000 Jun 12; 36(7):595-645. PubMed ID: 10771117
    [Abstract] [Full Text] [Related]

  • 9. Role of local anesthetics on both cholinergic and serotonergic ionotropic receptors.
    Arias HR.
    Neurosci Biobehav Rev; 1999 Jun 12; 23(6):817-43. PubMed ID: 10541058
    [Abstract] [Full Text] [Related]

  • 10. Quinacrine and ethidium bromide bind the same locus on the nicotinic acetylcholine receptor from Torpedo californica.
    Lurtz MM, Hareland ML, Pedersen SE.
    Biochemistry; 1997 Feb 25; 36(8):2068-75. PubMed ID: 9047305
    [Abstract] [Full Text] [Related]

  • 11. Interaction of lipids and ligands with nicotinic acetylcholine receptor vesicles assessed by electron paramagnetic resonance spectroscopy.
    Arias HR.
    Methods Mol Biol; 2010 Feb 25; 606():291-318. PubMed ID: 20013404
    [Abstract] [Full Text] [Related]

  • 12. Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism.
    Arias HR.
    Mol Membr Biol; 1995 Feb 25; 12(4):339-47. PubMed ID: 8747279
    [Abstract] [Full Text] [Related]

  • 13. Positive and negative modulation of nicotinic receptors.
    Arias HR.
    Adv Protein Chem Struct Biol; 2010 Feb 25; 80():153-203. PubMed ID: 21109220
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor.
    Arias HR, McCardy EA, Blanton MP.
    Mol Pharmacol; 2001 May 25; 59(5):1051-60. PubMed ID: 11306687
    [Abstract] [Full Text] [Related]

  • 15. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
    Arias HR.
    Arch Biochem Biophys; 1996 Sep 01; 333(1):1-11. PubMed ID: 8806747
    [Abstract] [Full Text] [Related]

  • 16. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
    Arias HR, Trudell JR, Bayer EZ, Hester B, McCardy EA, Blanton MP.
    Biochemistry; 2003 Jun 24; 42(24):7358-70. PubMed ID: 12809491
    [Abstract] [Full Text] [Related]

  • 17. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
    Blanton MP, Xie Y, Dangott LJ, Cohen JB.
    Mol Pharmacol; 1999 Feb 24; 55(2):269-78. PubMed ID: 9927618
    [Abstract] [Full Text] [Related]

  • 18. Examining the noncompetitive antagonist-binding site in the ion channel of the nicotinic acetylcholine receptor in the resting state.
    Blanton MP, McCardy EA, Gallagher MJ.
    J Biol Chem; 2000 Feb 04; 275(5):3469-78. PubMed ID: 10652341
    [Abstract] [Full Text] [Related]

  • 19. Regulation of ligand-gated ion channels by protein phosphorylation.
    Swope SL, Moss SJ, Raymond LA, Huganir RL.
    Adv Second Messenger Phosphoprotein Res; 1999 Feb 04; 33():49-78. PubMed ID: 10218114
    [Abstract] [Full Text] [Related]

  • 20. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
    Arias HR, Ortells MO, Feuerbach D.
    Neurochem Int; 2013 Nov 04; 63(5):423-31. PubMed ID: 23917086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.